Agilent Named Company of the Year by Instrument Business Outlook

Agilent Named Company of the Year by Instrument Business Outlook

Industry Newsletter Cites Technology Development, Operational and Financial Performance

SANTA CLARA, Calif., Jan. 22, 2018

Agilent Technologies Inc. (NYSE: A) today announced that it has been selected as 2017 Company of the Year by Instrument Business Outlook (IBO).

IBO is a respected industry newsletter that tracks trends in the laboratory products markets, monitoring hundreds of life science and analytical instrument companies on a daily basis.

Managing Editor Tanya Samazan noted: “Agilent has grown sales since fiscal 2015 while keeping costs constant. The company’s fiscal 2017 revenue growth was its fastest since fiscal 2010. Agilent’s new investments have also paid off. Changes include an expansion of Agilent’s diagnostics business, entry into new markets such as cell analysis and Raman spectroscopy, and additions to successful franchises in NGS sample preparation and LC/MS, among other key product launches.”

“We are pleased that IBO has recognized Agilent as their 2017 Company of the Year, citing our impressive growth,” said Mike McMullen, Agilent’s president and CEO. “Having the right strategy to secure growth is pivotal, but equally crucial is the right team, resolute in their commitment, and with one focus – to provide solutions and services which enable Agilent´s customers to be successful across the all the markets we serve.”

The newsletter highlighted Agilent’s increased growth in revenues, operating profit, and net income, noting that the gains were the result of a sustained effort to position the company for future growth.

“It is rewarding that an organization with an in-depth knowledge of the industry, such as IBO, recognizes Agilent´s current strategy is the right one resulting in consistent growth,” said Patrick Kaltenbach, president of Agilent’s Life Sciences and Applied Markets Group. “Growth fueled by our focus on Innovation with Purpose, introducing differentiated solutions to address customer needs, and our strong Operational Excellence in developing, manufacturing and commercialization of our products, all complemented by our recent acquisitions.”

IBO is a twice-monthly publication of SDi, a division of BioInformatics LLC, which offers custom market research and consulting, and strategic advisory services. IBO will present the award to Agilent at the annual conference of the Society for Laboratory Automation and Screening (SLAS) in San Diego in early February.